Skip to main content
ISOP ACoP 2025 Annual Conference Main banner

Stacey Tannenbaum, PhD, FISoP (she/her/hers)

Consultant and Coach to the MIDD Community
SJTPharm LLC
Northbrook, Illinois, United States

Stacey Tannenbaum, PhD, FISoP is a Consultant and Coach to the MIDD community, supporting the development of leadership, communication, and change management skills, at SJTPharm LLC.

Over her 25+ year career, Stacey has been a Pharmacometrician, leader, and consultant at Metrum Research Group, Astellas, and Novartis. Her education is in Biomedical Engineering, Pharmaceutical Sciences. and Applied Mathematics, and she completed a post-doctoral fellowship at the Center for Drug Development Science. Stacey has contributed to multiple drug development programs and successful submissions. Some of the outcomes of her work were optimization of dosing for future trials and labels, prediction of efficacy and safety with confidence, design of smarter studies and identification of key covariates, and bridging across populations, such as from healthy subjects to patients, and adults to children. As she transitioned from individual contributor into leadership roles, her expertise expanded beyond the science itself to include: championing science communication and soft skills development within technical teams, building infrastructure and implementing best practices for efficient and reproducible MIDD, guiding partners in translating clinical needs into strategic and model-informed solutions, and mentoring and training the next generation of leaders.

Stacey has had a significant impact on the global Pharmacometrics community. She co-founded ISoP, serving as its first President, and is an ISoP Fellow and Leadership Award recipient. Stacey co-founded the ACoP and was conference chair for the first three events; she remains an active volunteer in both ISoP and ACoP. She is the Executive Committee chair for WCoP, and is the chair of the Quantitative Pharmacology Network at ASCPT. She served as a board member of AAPS, chaired the AAPS M&S Focus Group, and was the co-chair for the AAPS Forum for Connecting Predictive Modelers. Stacey also co-founded the networking group Modeling and Simulation Applications in Clinical Pharmacotherapy (MoSAiC), now ISoP-NJ/NY/PA.

Disclosure information not submitted.

Presentation(s):

Email Stacey